DNA test may predict radiation side effects for prostate cancer patients
NCT ID NCT04624256
First seen Mar 19, 2026 · Last updated May 22, 2026 · Updated 10 times
Summary
This study looks at whether a DNA-based test can help predict which prostate cancer patients are more likely to have side effects from radiation therapy. About 208 men with early-stage prostate cancer will have their DNA tested for a marker linked to radiation sensitivity. Doctors and patients will see the results to help decide on the best radiation dose. The goal is to see if knowing this information can reduce long-term urinary side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE ADENOCARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
UCLA / Jonsson Comprehensive Cancer Center
Los Angeles, California, 90095, United States
Conditions
Explore the condition pages connected to this study.